*Dr Reddy's to sell Quetiapine in NZ* Hyderabad, Aug. 30
Pharma major Dr Reddy's Laboratories Ltd has received permission to sell Quetiapine in New Zealand from Pharmac, the drug-funding agency of New Zealand Government. Quetiapine is a drug indicated for treatment of manic and depressive dimensions of bipolar disorder. The drug would be introduced in New Zealand market from October 1 and Pharmac would fully fund (completely reimburse the expenses incurred) the drug made by the Hyderabad-based pharma company, a release said. At present, there are two players in New Zealand for supply of Quetiapine including AstraZeneca. Dr Reddy's would be the third player selling the drug. There are 34,000 patients in New Zealand who take Quetiapine. When contacted an official spokesperson of Dr Reddy's said: “We have received the approval to sell our brand of Quetiapine in NZ and hope to be a major player''. Dr Reddy's was actively working in New Zealand market and had plans to increase its presence in the coming months, he added. During last financial year, the company earned $7 millions revenue from New Zealand. – http://www.thehindubusinessline.com/2010/08/31/stories/2010083153080200.htm -- You received this message because you are subscribed to the Google Groups "Mental Health Advocacy (News 'N Views) India" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/MhaNewsViewsIndia?hl=en ------------- Affiliated Groups : MENTAL HEALTH ADVOCACY INDIA [email protected] Discussions on mental health law / policy / plan monitoring / human rights etc [email protected] India-specific news and views related to mental health [email protected] Information and support to carers of people with mental health issues [email protected] Mutual support and sharing of experiential knowledge, skills and social learning amongst peers
